Blog
Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc
Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc
Form 8.3 - The Vanguard Group, Inc.: Petershill Partners plc
Form 8.3 - The Vanguard Group, Inc.: Petershill Partners plc
Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The
EQS-News: BayWa AG launches second tranche of capital increase
EQS-News: BayWa AG launches second tranche of capital increase
EQS-Adhoc: PVA TePla AG: Announcement of preliminary results for the third quarter of 2025 and ad-justment of the forecast for 2025 due to project delays caused by trade pol-icy-related uncertainties
EQS-Adhoc: PVA TePla AG: Announcement of preliminary results for the third quarter of 2025 and ad-justment of the forecast for 2025 due to project delays caused by trade pol-icy-related uncertainties
EQS-Adhoc: UBS AG: Changes to the UBS Board of Directors
EQS-Adhoc: UBS AG: Changes to the UBS Board of Directors
EQS-Adhoc: Uniper SE: Uniper expects a significant decline in earnings for the nine months of the fiscal year 2025 in comparison to the previous year. Earnings outlook for fiscal year 2025 is confirmed
EQS-Adhoc: Uniper SE: Uniper expects a significant decline in earnings for the nine months of the fiscal year 2025 in comparison to the previous year. Earnings outlook for fiscal year 2025 is confirmed
EQS-Adhoc: UBS AG: Changes to UBS’s Group Executive Board
EQS-Adhoc: UBS AG: Changes to UBS’s Group Executive Board
EQS-News: Medios AG: Reallocation of Bencis shares
EQS-News: Medios AG: Reallocation of Bencis shares
EQS-News: The Platform Group AG: mwb research initiates coverage with BUY recommendation and price target of EUR 19.50
EQS-News: The Platform Group AG: mwb research initiates coverage with BUY recommendation and price target of EUR 19.50
EQS-News: Mutares signs agreement to acquire M3 Group in Sweden
EQS-News: Mutares signs agreement to acquire M3 Group in Sweden
EQS-News: All for One Group successfully places promissory note loan // Significant oversubscription
EQS-News: All for One Group successfully places promissory note loan // Significant oversubscription
EQS-News: Ottobock makes follow-on cornerstone investment in NeuroTech company ONWARD® Medical
EQS-News: Ottobock makes follow-on cornerstone investment in NeuroTech company ONWARD® Medical
EQS-News: Circus SE Secures Core Technologies Through Six New Defense Patents
EQS-News: Circus SE Secures Core Technologies Through Six New Defense Patents
EQS-Adhoc: BB Biotech AG publishes its interim report
EQS-Adhoc: BB Biotech AG publishes its interim report
EQS-News: BB Biotech Q3 2025: Portfolio outperformance amid early signs of sector recovery
EQS-News: BB Biotech Q3 2025: Portfolio outperformance amid early signs of sector recovery
Relief Therapeutics Convenes Extraordinary General Meeting
Relief Therapeutics Convenes Extraordinary General Meeting
HBM Healthcare Investments publishes Half-Year Report as at 30 September 2025 with key figures for the first six months of the 2025/2026 financial year
HBM Healthcare Investments publishes Half-Year Report as at 30 September 2025 with key figures for the first six months of the 2025/2026 financial year
